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Resource utilization among kidney transplant recipients.
Background. Hospitalization consumes a significant portion
of the end-stage renal disease (ESRD) program, which includes
kidney transplant recipients. Identification of kidney transplant
recipients at risk of increased resource utilization could lead
to appropriate interventions to attenuate the complications
related to kidney transplant, which may reduce resource utiliza-
tion.
Methods. This retrospective cohort study of kidney trans-
plant recipients was performed to identify risk factors for hospi-
tal utilization. The study population consisted of patients who
received kidney transplant at our center between October 1990
and September 1999 and were followed in the outpatient clinic.
Results. Of the 220 patients, 171 (78%) were hospitalized
during a median follow-up of 36 months. The number of hospi-
talizations, hospital days, and outpatient visits per patient-year
at risk were 1.1, 6.3, and 21.6, respectively. Infection episodes
were the leading cause of hospitalization. In a multivariate
regression analysis, cytomegalovirus (CMV)-positive status of
donor (RR 1.58; 95% CI 1.15, 2.18) and a higher number of
hospital days during the transplant hospitalization (RR 1.10
per 7 days increase; 95% CI 1.03, 1.19) were associated with
a higher risk of hospitalization, while higher serum albumin
(RR 0.84 per 0.5g/dL increase; 95% CI 0.73, 0.97), higher hema-
tocrit (RR 0.95 per 1% increase; 95% CI 0.92, 0.98), higher
glomerular filtration rate (GFR) (RR 0.91 per 10 mL/min/
1.73 m2; 95% CI 0.85, 0.99), and an increased interval since
transplant (RR 0.84 per 6 months increase; 95% CI 0.75, 0.93)
were associated with a lower risk of hospitalization. CMV-
positive status of the donor (RR 1.11; 95% CI 1.00, 1.21) and
presence of cardiovascular disease (RR1.12; 95% CI 1.00, 1.24)
were associated with a higher risk of outpatient visits, while
Caucasian race (RR 0.82; 95% CI 0.73, 0.94), higher serum
albumin (RR 0.88 per 0.5 g/dL increase; 95% CI 0.84, 0.93),
higher hematocrit (RR 0.96 per 1% increase; 95% CI 0.95,
0.97), and an increased interval since transplant (RR 0.79 per
6 months increase; 95% CI 0.76, 0.83) were associated with a
lower risk of outpatient visits.
Conclusion. Identification of risk factors associated with in-
crease resource utilization among kidney transplant recipients
could aid in the development of targeted interventions to im-
prove clinical and economic outcomes.
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Hospital utilization consumes a significant portion of
the United States health care spending. Of the total
$1.15 trillion in 1998 health care expenditure, the largest
proportion, $383 billion (33%), was spent on hospital
care [1]. As health care expenditures continue to esca-
late, health care providers are seeking measures to con-
strain costs, while maintaining standards of patient care
and quality of life. The allocation of finite resources in a
manner acceptable to the health care providers, consum-
ers, economists, and policy makers is the real challenge
in the future. Dealing with this challenge, which domi-
nated the health care policy debate for the last few de-
cades, will be extremely difficult. Any strategy for reduc-
ing health care spending should focus on the area of
greatest cost, hospital utilization.
Cost per patient is likely to accelerate over the next
decade as the mix of patients accepted for renal replace-
ment therapy shifts toward the elderly and patients with
higher number of comorbid conditions. Kidney transplant
recipients, who constituted 29% [2] of total end-stage
renal disease (ESRD) population in 1999, are covered
by Medicare during the first 3 years after transplantation.
The annual Medicare cost for kidney transplantation in
1999 was $717 million, which is 8% of the total ESRD
Medicare budget [2].
Chronic kidney disease (CKD) is an important public
health problem in the United States. Kidney transplant
recipients are considered a subset of patients with CKD
[3], and consequently are at risk for complications associ-
ated with CKD. These complications and comorbid con-
ditions result in increased morbidity and mortality, as
well as increased resource utilization [4–9]. Any attempts
to reduce the resource utilization among the kidney trans-
plant recipients would require the identification of fac-
tors associated with higher risk of resource utilization.
This eventually may allow the development of interven-
tions that could reduce the morbidity and cost in this
population. Once we define the current and future need
of kidney transplant recipients at risk for higher resource
utilization, health care providers can position themselves
to improve clinical and economic outcomes.
We studied the prevalence, patterns, and causes of
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and factors associated with hospitalization during post-
transplant period in a retrospective longitudinal analysis
of patients who received kidney transplant at a tertiary
care center between October 1990 and September 1999.
METHODS
Patient population
The study sample consisted of patients who underwent
kidney transplantation at Tufts–New England Medical
Center between October 1, 1990 and September 30, 1999.
Posttransplant data collection was extended through
September 30, 2000, to allow a minimum of 1 year of
follow-up for all patients. Patients were included if they
were 18 years of age or older.
Data sources and collection
Data were abstracted by physician investigators from
the inpatient, nephrology, and transplant surgery outpa-
tient clinic charts and from Clinical Information Systems
(CIS), a computerized patient database that contains
laboratory results, hospitalization, and outpatient clinic
data, and other hospital-based care data at Tufts–New
England Medical Center. Data were directly entered into
a Microsoft Access database. Data on outpatient clinic
visits other than nephrology visits were obtained from
the hospital cost accounting system, Transitional System
Inc. (TSI).
Baseline data at the time of kidney transplantation
included patient demographic information such as age
at transplantation, gender, and race, clinical information
such as primary cause and duration of ESRD, comorbid
conditions, modality of renal replacement therapy prior
to transplantation, history of prior kidney transplant; and
transplant-related information such as type of kidney
donor, viral serology, use of induction immunosuppres-
sion with OKT3, antithymocyte globulin (ATG) or an
interleukin-2 (IL-2) receptor antagonist (IL-2RA), and
occurrence of delayed graft function. Medication use and
laboratory data were recorded as available in charts.
Longitudinal data were collected monthly for the first 6
months after transplantation and then every 3 months
until the end of the study period, the occurrence of graft
failure, transfer of care to a different institution, death,
or loss to follow-up, whichever occurred earlier. Data
collection at each point included outpatient blood pres-
sure, weight and laboratory data, medication use, hospi-
talization data, including occurrence and treatment of
acute rejection, and the reason for last follow-up. If a
laboratory value was not available coincident with the
visit, the value closest to the visit within 15 days was
used during the first 6 months of follow-up, and the value
closest to the visit within 30 days was used beyond 6
months after transplantation.
Data categorization
Race was categorized as Caucasian, African Ameri-
can, Asian, or other. Cause of kidney failure was classi-
fied as diabetes, hypertension, glomerulonephritis/inter-
stitial nephritis/polycystic kidney disease (GN/IN/PKD),
and other. All use of immunosuppressive agents, antihy-
pertensive medications, lipid-lowering agents, anticoagu-
lants, erythropoietin, phosphate binders, and vitamin D
were recorded. Medications recorded in the clinic chart
were assumed to be used by the patients. No attempt was
made to determine actual medication adherence. Epi-
sodes of acute rejection were identified from hospitaliza-
tion records. Confirmation of the diagnosis of acute re-
jection by kidney biopsy was documented, if performed.
The cause of hospitalization was considered to be the
primary diagnosis listed on the discharge summary. The
causes of hospitalization were categorized as rejection,
infection, kidney biopsy (with no evidence of rejection),
kidney related causes other than rejection, cardiovascu-
lar, cerebrovascular, and peripheral vascular disease,
gastrointestinal, pulmonary and other (including electro-
lyte abnormalities, psychiatric disorders, hepatobiliary
disease, malignancy and all other causes that were less
defined).
Definitions and equations
Five common comorbid conditions were separately
determined at baseline: (1) cardiovascular disease, (2)
peripheral vascular disease, (3) cerebrovascular disease,
(4) hypertension, and (5) diabetes. Glomerular filtration
rate (GFR) was predicted using an equation derived
from the results of the Modification of Diet in Renal
Disease (MDRD) Study (abstract; Levey et al, J Am Soc
Nephrol 11:155A, 2000), which is based on age, gender,
race, and serum creatinine. Delayed graft function was
considered if dialysis was required after transplantation.
End point definitions and ascertainment
The outcomes of interest in this analysis were time
to first hospitalization after discharge from transplant
surgery, number of hospitalizations, and outpatient clinic
visits during the first 3 years after transplantation. Time
to first hospitalization was the time between discharge
after transplant surgery and first hospitalization.
Statistical analysis
Descriptive statistics of baseline characteristics were
performed for the entire study sample. Results of contin-
uous variables are presented as mean  standard devia-
tion (SD) and discrete variables as proportions.
All hospitalizations, excluding the transplant hospital-
ization during the first 3 transplant years, were used
to calculate the hospitalizations and hospital days per
patient-year at risk. The number of hospitalizations, hos-
pital days, and outpatient visits per patient-year at risk
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were obtained by dividing the total number of hospital-
izations, hospital days, and outpatient visits observed by
the total calculated patient-years at risk of the entire
cohort. The total number of hospital days was subtracted
from time at risk for analyses of number of hospitaliza-
tions and outpatient visits, since patients were not at risk
of being hospitalized or having an outpatient visit.
Since the causes of and factors associated with hospi-
talizations and outpatient visits were likely to change over
time, two different regression models were used. Cox
regression with time-dependent covariates was used to
examine the association between baseline demographic,
time-dependent clinical and laboratory variables, and
time to first hospitalization. In this analysis, the counting
process style of input was used, where multiple records
were created for each patient, one record for each dis-
tinct pattern of the time-dependent measurements. Each
record contained a T1 (first day of interval) value and
a T2 (last day of interval) value representing the time
interval (T1, T2) during which the values of the explana-
tory variables remain unchanged. Each record also con-
tained the censoring status at T2. The advantage of using
time-dependent covariates in a Cox model is the ability
to predict outcomes while allowing the covariates values
to change over time. Generalized estimating equation
(GEE) regression with Poisson link function was used
to analyze the number of hospitalization and outpatient
visits. In addition to evaluating the relative risk of multi-
ple events, changes over time in independent variables
are also incorporated in this analysis. GEE analysis ac-
counts for the correlated measurement of within-patient
outcomes and factors through the specification of a work-
ing correlation structure; robust standard error estimates
of the model’s coefficients were used. These estimates
have the property of providing consistent estimates of
the standard errors even if the working correlation ma-
trix is misspecified. [10] As much variability was expected
during the earlier posttransplant period, the first year
was divided into four 3-month periods and the next 2
years were divided into four 6-month periods. GEE anal-
ysis captures covariates, which change over time and may
have a potential impact on resource utilization, including
hematocrit, serum albumin, and GFR. Covariates from
each period were used to predict the resource utilization
during the following period. All multivariate models
were constructed using stepwise selection of independent
variables with probability values from univariate analysis
of0.10. All models were adjusted for age, gender, race,
diabetes, and cytomegalovirus (CMV) status. Statistical
analyses were performed using SAS System for Windows
(version 8.00, SAS Institute, Inc., Cary, NC, USA).
RESULTS
A total of 240 patients received kidney transplants
during the study period. Twenty patients were excluded
from the analyses of whom, 13 patients underwent ne-
phrectomy during their hospitalization for transplant sur-
gery, five patients were transferred out and had no fur-
ther follow-up visits, and the discharge date could not
be identified in two patients. Thus, the final study cohort
included 220 patients. Median follow-up was 3 years. Six
percent of the patients progressed to kidney failure, 6%
were transferred to other facilities, 5% were lost to fol-
low-up, 3% died, and 80% were followed in clinic until
3 years posttransplant.
Patient and laboratory characteristics
The mean age was 45  13 years, 7% of the patients
were older than 65 years, 39% were female, and 80%
were Caucasian. The cause of CKD was diabetes in 17%,
hypertension in 14%, GN/IN/PKD combined in 54%, and
a variety of other causes in 15%. Hypertension was pres-
ent in 96%, diabetes in 21%, cardiovascular disease in
37%, peripheral vascular disease in 9%, and cerebrovas-
cular disease in 5%. Cadaveric transplant accounted for
50%, living related for 42%, and living unrelated for 8%
of kidney transplants. Delayed graft function was present
in 10% of the patients. Fifty two percent of the donors
and 48% of the recipients were CMV positive.
Among the 220 patients, 171 (78%) were hospitalized
during the 3 years of follow-up. Patients who were hospi-
talized had a higher prevalence of current smoking (26%
vs. 10%, P  0.029), kidney from a CMV-positive donor
(58% vs. 33%, P  0.002), and delayed graft function
(12% vs. 0%, P  0.01). Other factors were not signifi-
cantly different between the two groups.
Hospitalizations. There were a total of 577 hospital-
izations, and 62% (361) of the total hospitalizations oc-
curred during the first year after transplantation. Thirty
nine percent of the patients were hospitalized within
1 month, and 50% within 3 months of discharge after
transplantation. The median number of hospital days for
transplant hospitalization was 10 days. There were 1.1
hospitalizations, and 6.3 hospital days per patient-year
at risk during the first 3 years after transplantation.The
distribution of hospitalization causes during the 3 years
after transplantation is presented in Figure 1.
Table 1 presents the changing patterns of resource
utilization, laboratory measures, and medication use
over the 3 years of follow-up. The number of hospitaliza-
tions, hospital days, and outpatient visits steadily de-
creased over time.
The causes of hospitalization varied over time (Table
1). Acute rejection was the most common cause of hospi-
talization during the first 3 months after transplantation.
Infections were the most common cause of hospitaliza-
tion during the rest of the study period.
Time to first hospitalization. Univariate analyses using
changing variables over time revealed a higher risk of
hospitalization associated with delayed graft function
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Fig. 1. Causes of hospitalizations during 3
years after kidney transplant (N  577).
Table 1. Changing resource utilization, laboratory measures and medications over time after kidney transplantation
Time months 0–6a 7–12 13–18 19–24 25–30 31–36
Resource utilization
Mean number of hospitalizations 1.2 0.4 0.3 0.3 0.3 0.3
Mean number of hospital days 7.6 2.5 1.3 1.9 1.8 1.5
Mean number of outpatient visits 22 10 6 6 6 6
Leading causes of hospitalization
Rejection 20% 6% 8% 5% 13% 13%
Infection 17% 18% 21% 29% 15% 15%
Renal (causes other than rejection) 22% 17% 5% 9% 14% 13%
Laboratory measures
Mean hematocrit % 36.3 40.3 40.0 39.1 38.4 37.9
Mean albumin g/dL 3.8 3.9 3.9 3.9 3.9 3.9
Mean GFR mL/min/1.73 m2 51 51 50 48 47 45
Medications use
ACEI 25% 25% 25% 30% 32% 33%
Erythropoietin 7% 3% 2% 3% 3% 4%
Azathioprine 72% 69% 69% 72% 73% 77%
Mycophenolate 28% 31% 31% 28% 27% 23%
Cyclosporin 88% 88% 88% 90% 91% 87%
FK506b 12% 12% 12% 10% 9% 13%
Abbreviations are: GFR, glomerular filtration rate; ACEI, angiotensin-converting enzyme inhibitor.
a Time from kidney transplantation
b Tacrolimus
(RR 2.22; 95% CI 1.40, 3.53), CMV-positive status of
the donor (RR 1.53; 95% CI 1.10, 2.12), higher number
of medications (RR 1.12 per medication increase; 95%
CI 1.01, 1.25), and increased number of hospital days
during the transplant hospitalization (RR 1.13 per 7 days
increase; 95% CI 1.05, 1.21). There was a lower risk of
hospitalization among patients with higher GFR (RR
0.82 per 10 mL/min/1.73 m2; 95% CI 0.75, 0.89), higher
serum albumin (RR 0.80 per 0.5g/dL increase; 95% CI
0.67 0.95), and higher hematocrit (RR 0.95 per 1% in-
crease; 95% CI 0.92, 0.99). In the multivariate analysis
adjusted for age, gender, race, diabetes and CMV status
of the donor, increased number of hospital days during
transplant hospitalization (RR 1.11 per 7 days increase;
95% CI 1.03, 1.21) were associated with a higher risk of
hospitalization, while higher GFR (RR 0.79 per 10 mL/
min/1.73 m2 increase; 95% CI 0.72, 0.87), and higher
serum albumin (RR 0.76 per 0.5 g/dL increase; 95% CI
0.64 0.91) were associated with a lower risk of hospital-
ization (Table 2).
Risk of hospitalization during the first 3 years after trans-
plantation. Univariate analyses using the GEE method
revealed a higher risk of hospitalization among smokers
(RR 1.61; 95% CI 1.07, 2.44), diabetics (RR 1.53; 95%
CI 1.01, 2.31), cadaveric kidney transplant recipients
(RR 1.41; 95% CI 1.01, 1.99), and patients with increased
number of hospital days during the transplant hospital-
ization (RR 1.14 per 7 days increase; 95% CI 1.06, 1.23).
There was a lower risk of hospitalization among those
who were Caucasian (RR 0.60; 95% CI 0.41, 0.86), pa-
tients with higher serum albumin (RR 0.67 per 0.5g/dL
increase; 95% CI 0.58, 0.77), and higher hematocrit (RR
0.91 per 1% increase; 95% CI 0.89, 0.93). In the multivar-
iate analysis adjusted for age, gender, race, diabetes, and
CMV status of the donor, CMV-positive status of the
donor (RR 1.58; 95% CI 1.15, 2.18), and increased num-
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Table 2. Risk of hospitalization among kidney transplant recipients (time to first hospitalization): A multivariate analysis
Variables RRa ( 95% CI) P value
Age in years (vs. 30–60)
30 years 2.16 (1.34, 3.48) 0.002
60 years 1.47 (0.96, 2.24) 0.074
Male (vs. female) 1.20 (0.87, 1.66) 0.260
Caucasian (vs. non-caucasian) 1.14 (0.76, 1.69) 0.529
Diabetes (vs. nondiabetic) 0.93 (0.63, 1.36) 0.707
Cytomegalovirus-positive donor (vs. negative donor) 1.51 (1.09, 2.09) 0.014
Glomerular filtration rate (per 10 mL/min/1.73 m2 increase) 0.79 (0.72, 0.87) 0.001
Albumin (per 0.5 g/dL increase) 0.76 (0.64, 0.91) 0.003
Hospital days (per 7 days increase)b 1.11 (1.03, 1.21) 0.010
a Time-dependent Cox Model
b Hospital days during hospitalization for kidney transplant
Table 3. Risk of hospitalization among kidney transplant recipients during the first 3 years after kidney transplantation:
A multivariate analysis
Variables RRa (95% CI ) P value
Age at transplant (per 10 years increase) 0.95 (0.83, 1.09) 0.475
Male (vs. female) 1.01 (0.74, 1.38) 0.957
Caucasian (vs. non-caucasian) 0.69 (0.49, 0.98) 0.037
Diabetes (vs. nondiabetic) 1.39 (0.94, 2.04) 0.100
Cytomegalovirus-positive donor (vs. negative donor) 1.58 (1.15, 2.18) 0.005
Glomerular filtration rate (per 10 mL/min/1.73 m2 increase) 0.91 (0.85, 0.99) 0.020
Hematocrit (per 1% increase) 0.95 (0.92, 0.98) 0.001
Albumin (per 0.5 g/dL increase) 0.84 (0.73, 0.97) 0.020
Hospital daysb (per 7 days increase) 1.10 (1.03, 1.19) 0.008
Interval since transplant (per 6 months increase) 0.84 (0.75, 0.93) 0.001
a Generalized estimation equation model
b Hospital days during hospitalization for kidney transplant
ber of hospital days during transplant hospitalization
(RR 1.10 per 7 days increase; 95% CI 1.03, 1.19) were
associated with a higher risk of hospitalization, while
longer interval since kidney transplantation (RR 0.84
per 6 months increase; 95% CI 0.75, 0.93), higher GFR
(RR 0.91 per 10 mL/min/1.73 m2 increase; 95% CI 0.85,
0.99), higher serum albumin (RR 0.84 per 0.5 g/dL in-
crease; 95% CI 0.73 0.97), and higher hematocrit (RR
0.95 per 0.5g/dL increase; 95% CI 0.92, 0.98) were sig-
nificantly associated with lower risk of hospitalization
(Table 3).
Risk of outpatient visits. Robust data on outpatient
visits from Tufts–New England Medical Center account-
ing system were available only after September 30, 1993.
Thus, only 167 patients were included in this analysis.
There were 22 visits per patient-year at risk during first
3 years after transplantation. Nephrology visits followed
by transplant surgery visits were the most common
causes of outpatient visits. The distribution of outpatient
clinic visits is presented in Figure 2.
Univariate analyses using the GEE method revealed
a higher risk of outpatient visits among patients with
cardiovascular disease (RR 1.24; 95% CI 1.08, 1.43),
cadaveric kidney recipients (RR 1.23; 95% CI 1.08, 1.41),
and use of erythropoietin (RR 1.87; 95% CI 1.42, 2.46).
There was a lower risk of outpatient visits among those
who were Caucasian (RR 0.73; 95% CI 0.62, 0.85), pa-
tients with higher serum albumin (RR 0.68 per 0.5 g/dL
increase; 95% CI 0.60, 0.76), and higher hematocrit (RR
0.91 per 1% increase; 95% CI 0.90, 0.92). In the multivar-
iate analysis adjusted for age, gender, race, diabetes and
CMV status of the donor, a higher risk of outpatient
visits was associated with CMV-positive status of the
donor (RR 1.11; 95% CI 1.00, 1.22) and presence of
cardiovascular disease (RR 1.12; 95% CI 1.00, 1.24),
while a lower risk of outpatient visits was associated with
Caucasian race (RR 0.82; 95% CI 0.71, 0.93), higher
serum albumin (RR 0.88 per 0.5 g/dL increase; 95%
CI 0.84, 0.93), higher hematocrit (RR 0.96 per 0.5 g/dL
increase, 95% CI 0.95, 0.97), and longer interval since
transplantation (RR 0.84 per 6 months increase; 95% CI
0.75, 0.93) (Table 4).
DISCUSSION
We observed substantial resource utilization among
kidney transplant recipients during a median follow-up
of 36 months after kidney transplantation. Indeed, 78%
of patients had at least one hospitalization and there
were on average 1.1 hospitalizations, 6.3 hospital days,
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Fig. 2. Distribution of outpatient visits dur-
ing 3 years after kidney transplant (N 8182).
ENT is ear, nose, and throat.
Table 4. Risk for outpatient visits during the first 3 years after kidney transplantation: A multivariate analysis
Variables RRa (95% CI) P value
Age at transplant (per 10 years increase) 1.01 (0.97, 1.06) 0.526
Male (vs. female) 1.05 (0.95, 1.16) 0.362
Caucasian (vs. non-caucasian) 0.82 (0.71, 0.93) 0.003
Diabetes (vs. non-diabetic) 1.11 (0.99, 1.26) 0.075
Cytomegalovirus-positive donor (vs. negative donor) 1.11 (1.00, 1.22) 0.042
Cardiovascular disease (vs. no cardiovascular disease) 1.12 (1.00, 1.24) 0.045
Hematocrit (per 1% increase) 0.96 (0.95, 0.97) 0.001
Albumin (per 0.5 g/dL increase) 0.88 (0.84, 0.93) 0.001
Interval since transplant (per 6 months increase) 0.79 (0.76, 0.83) 0.001
a Generalized estimation equation model
and 22 outpatient visits per patient-year at risk. Except
for the first quarter, where rejection episodes were the
major cause of hospitalization, infections remained the
most common cause of hospitalization. Multivariate anal-
yses incorporating changes in covariates over time re-
vealed that CMV-positive status of donor and higher
number of hospital days during transplant hospitaliza-
tion were associated with a higher risk of hospitalization,
while higher GFR, higher serum albumin, higher hema-
tocrit, and increased time since transplant were associ-
ated with a lower risk of hospitalization. In addition,
CMV-positive status of donor and presence of cardiovas-
cular disease were associated with a higher risk of outpa-
tient visits, while higher serum albumin, higher hemato-
crit, and increased time since transplant were associated
with a lower risk of outpatient visits.
The results of our study confirm a higher rate of hospi-
talization during first year after kidney transplantation.
During the second and third year after kidney trans-
plantation, the mean number of hospitalizations (0.29 to
0.34 per person) and hospital days (1.3 to 1.9 per person)
among kidney transplant recipients were similar to the
general population (0.31 hospitalizations and 1.9 hospital
days per person) [11]. However, the hospitalization rates
(1.1 hospitalizations and 6.3 hospital days per patient-
year at risk) among kidney transplant recipients were
lower when compared to the dialysis population (2.2
hospitalizations and 14.8 hospital days per patient-year
at risk) [12], at our institution. The younger age, lower
comorbidity, or simply the better outcomes after the
kidney transplantation could explain the utilization rates
a year after kidney transplantation being more like the
general population than the dialysis population.
The causes of hospitalization in our study varied over
time. Acute rejection episodes, a predictor of chronic
rejection [13], and graft survival [14, 15] were the most
common cause of hospitalization during the first 3 months
after transplantation. Posttransplant infections were the
leading cause of hospitalization during rest of the study
period. Previous studies have shown that the infections
are the result of overall immunosuppression [16] reacti-
vation of latent infection, presence of indwelling cathe-
ter, nutritional status, hyperglycemia, and infection sec-
ondary to immunomodulating viruses [17–19]. However,
our data did not further specify the exact nature of the
infections. Although certain immunosuppressive regi-
mens have been shown to be associated with a higher
risk of infection [20–21], our study did not confirm such
relationship. Surprisingly, cardiovascular disease, the most
common cause of hospitalization (25%) among CKD
patients at our institution [22], accounted for only 7.6%
of hospitalizations. Since the prevalence (40% vs. 37%)
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of cardiovascular disease among kidney transplant recip-
ients was similar to that in the CKD patients, the over-
whelming presence of transplant-related complications
might be an explanation for relatively infrequent hospi-
talizations due to cardiovascular disease. Comorbid con-
ditions such as cardiovascular disease, ischemic heart
disease, and peripheral vascular disease have been shown
to be associated with increased hospitalizations among
ESRD [12, 23], predialysis [8], and CKD patients [22].
Our study showed a lack of such a relationship with
hospitalizations. These results may again reflect the over-
whelming presence of transplant-related factors as stronger
predictors of hospitalization during the posttransplant
period.
Lower GFR was significantly associated with a higher
risk of hospitalization in both the Cox and GEE multi-
variate regression analyses. Holland and Lam [8] had
noted a similar relationship among predialysis patients.
In their study, patients with serum creatinine levels3.4
mg/dL had a 64% increased risk of hospitalization [8].
In contrast, GFR was not significantly associated with
any of the measures of resource utilization among CKD
patients at our institution [22]. The impact of GFR on
hospitalization could be attributed to its association with
rejection episodes, since these were the second most
common cause of hospitalization. Further analysis using
hospitalizations due to rejection as a variable in the
model continued to show lower GFR as a predictor of
increased hospitalization.
Anemia of CKD has been incriminated as an impor-
tant cause of cardiovascular disease. The association of
anemia with increased resource utilization among dial-
ysis [24, 25], predialysis [8], and CKD patients [22] has
been well established. We found a significant association
between posttransplant anemia and resource utilization
in this study. Each 1% increase in hematocrit was associ-
ated with a 5% lower risk of hospitalization. Posttrans-
plant anemia is a result of acute rejections [26], delayed
graft function, recurrent infections, iron deficiency [27],
and the delayed endogenous erythropoietin secretion
[28, 29]. Yet, due to multiple other overwhelming issues
encountered during posttransplant period, anemia had
received little attention. A recent study of 4643 patients
returning to dialysis after a failed kidney transplant re-
vealed a mean hematocrit of 27.5% at the time of dialysis
initiation [30]. Whether prevention of posttransplanta-
tion anemia or early recognition and treatment can re-
duce utilization remains unanswered.
Lower serum albumin levels have previously been
shown to be associated with increased hospital utilization
[12, 23] and mortality [31, 32] in the ESRD population.
In the current study, higher serum albumin was indepen-
dently associated with all measures of resource utiliza-
tion. Each 0.5 g/dL increase in serum albumin was associ-
ated with a 24% lower risk in time to first hospitalization
and 16% lower risk in overall hospitalizations. In addi-
tion to being a nutritional marker, serum albumin is
also a marker of inflammation [33]. Transplant recipients
have several potential sources of inflammation such as
infections and rejections. Consequently, the relationship
between serum albumin and hospitalization could be a
reflection of these conditions.
CMV, since its identification in kidney transplant re-
cipient in 1965 [34], continues to be a common cause of
morbidity and mortality [35]. In our study, kidney from
a CMV-positive donor was an independent risk factor
for increase resource utilization [35]. We analyzed the
relationship of four possible combinations of CMV do-
nor/recipient status with resource utilization. Regardless
of recipient status, CMV-positive status of the donor
kidney was independently associated with increased re-
source utilization. The increased number of rejection
episodes, anemia due CMV prophylaxis, and the inten-
sive treatment requiring hospitalization for CMV disease
among recipients of CMV-positive kidney transplant
could contribute to the increased hospitalization.
The frequency and patterns of outpatient utilization
among kidney transplant recipients have not been pre-
viously studied. Interestingly, visits to nephrologists and
transplant surgeons accounted for 75% of total outpa-
tient utilization. This emphasizes the fact that most of
the care of transplant recipients is provided in the office
of the nephrologist or transplant surgeon. Consequently
CKD care (or lack of care) among transplant recipients
is directly attributable to the vigilance of this group of
caregivers.
The results of this study must be interpreted with its
limitations in mind. It is a retrospective study with vari-
able ascertainment of data and follow-up. Specifically,
hospitalizations outside of Tufts–New England Medical
Center were not reliably captured. This study examined
a limited group of kidney transplant recipients to study
the factors associated with resource utilization. The ret-
rospective nature of the study only allows an analysis of
association and not causation. The patient characteristics
and care provided at our center might not be generaliz-
able, since the population, clinical practices, and resource
utilization varies considerably among kidney transplant
centers. Nonetheless, this study provides a list of poten-
tially modifiable factors, interventions for which could
reduce hospitalization and cost among transplant recipi-
ents.
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